首页 | 本学科首页   官方微博 | 高级检索  
     


Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma
Authors:R Czerninski  S Krichevsky  Y Ashhab  D Gazit  V Patel  D Ben-Yehuda
Affiliation:Department of Oral Medicine, Hebrew University-Hadassah School of Dental Medicine, Jerusalem, Israel;;Department of Hematology, Hebrew University - Hadassah Medical Center, Jerusalem, Israel;;Skeletal Biotechnology Laboratory, Hebrew University-Hadassah Medical Center, Jerusalem, Israel;;Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
Abstract:Objectives:  Major risk factors of oral squamous cell carcinoma (OSCC) are environmental and can lead to DNA mutagenesis. Mismatch repair (MMR) system functions to repair small DNA lesions, which can be targeted for promoter hypermethylation. We therefore wanted to test whether hypermethylation of MMR genes ( hMLH1, hMSH2 ) could contribute to oral carcinogenesis by correlating the information to patient clinical data.
Methods:  Genomic DNA was extracted from 28 OSCC and six normal oral epithelium samples. The methylation status of the two MMR genes was assessed using Methylation Specific PCR after DNA modification with sodium bisulfite. Serial sections of the same tissues were immunostained with antibodies against hMLH1 and hMSH2 protein.
Results:  Promoter hypermethylation was observed in 14/28 OSCC cases. Remarkably, 100% of patients with multiple oral malignancies showed hypermethylation in hMLH1 or hMSH2 compared with 31.5% of single tumor patients. In 10 cancer cases, expression of the hMLH1 and hMSH2 genes by immunostaining showed reduced or absence of expression of one of the genes, although some did not reflect the methylation status.
Conclusions:  Hypermethylation of hMLH1 and hMSH2 might play a role in oral carcinogenesis and may be correlated with a tendency to develop multiple oral malignancies.
Keywords:oral cancer    hypermethylation    hMLH1    hMSH2    multiple malignancies
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号